RxDoctor Payments Data

Stephen Wigley

Foot & Ankle Surgery · North Miami Beach, FLNPI 1184913097

Payments from drug & device makers

$26,010in general payments, 2019–2025

Across 146 payments — averaging $178.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acumed LLC$15K
  • Acera Surgical, Inc.$5K
  • Stryker$2K
  • Southern Edge Orthopaedics, Inc.$1K
  • Smith+Nephew$438
  • Paragon 28, Inc.$250
  • plus $2K from 30 others

What the payments were for

  • Consulting fees$8,50033%
  • Speaking & faculty fees$1,3005%
  • Travel & lodging$3,60314%
  • Food & beverage$6,26724%
  • Education$1,1745%
  • Gifts$1270%
  • Other$5,04019%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,010 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$2,368,306
Medicare patients
163
Services billed
2,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole5,612$74,984
Ciclopirox2,321$52,557
Ammonium Lactate3,457$51,852
CiclopiroxCiclopirox Olamine748$16,082
SantylCollagenase Clostridium Hist.26$14,534
Diclofenac Sodium176$3,423
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip125$2,325
Gentamicin Sulfate34$1,319
Methylprednisolone174$1,080
Lidocaine13$699
Cephalexin58$623
Terbinafine Hcl27$459
Doxycycline Hyclate72$443
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc37$400
Triamcinolone Acetonide22$320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$438$14,53426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 850 foot & ankle surgery providers in Florida.

Other foot & ankle surgery in North Miami Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →